The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

In this study, we determined the efficacy of the cell death biomarker cytokeratin 18 for diagnosing biliary tract cancer (BTC). We recruited 36 patients with BTC (Malignant group) and 45 patients with benign biliary tract disease (Benign group) for this study. We used M30 and M65 as cell death bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Mitsuru, Abe, Kazumichi, Hayashi, Manabu, Takagi, Tadayuki, Suzuki, Rei, Konno, Naoki, Asama, Hiroyuki, Sato, Yuki, Irie, Hiroki, Watanabe, Ko, Nakamura, Jun, Kikuchi, Hitomi, Waragai, Yuichi, Takasumi, Mika, Hashimoto, Minami, Hikichi, Takuto, Nozawa, Yoshihiro, Ohira, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243019/
https://www.ncbi.nlm.nih.gov/pubmed/30451962
http://dx.doi.org/10.1038/s41598-018-35278-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243019/
https://www.ncbi.nlm.nih.gov/pubmed/30451962
http://dx.doi.org/10.1038/s41598-018-35278-7

Ejemplares similares